Cargando…
A synergistic small molecule combination directly eradicates diverse prion strain structures
Safely eradicating prions, amyloids and preamyloid oligomers may ameliorate several fatal neurodegenerative disorders. Yet, whether small-molecule drugs can directly antagonize the entire spectrum of distinct amyloid structures or ‘strains’ that underlie distinct disease states is unclear. Here, we...
Autores principales: | Roberts, Blake E., Duennwald, Martin L., Wang, Huan, Chung, Chan, Lopreiato, Nicholas P., Sweeny, Elizabeth A., Knight, M. Noelle, Shorter, James |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909773/ https://www.ncbi.nlm.nih.gov/pubmed/19915541 http://dx.doi.org/10.1038/nchembio.246 |
Ejemplares similares
-
Evidence for preexisting prion substrain diversity in a biologically cloned prion strain
por: Gunnels, Tess, et al.
Publicado: (2023) -
A structural basis for prion strain diversity
por: Manka, Szymon W., et al.
Publicado: (2023) -
Small Heat Shock Proteins Potentiate Amyloid Dissolution by Protein Disaggregases from Yeast and Humans
por: Duennwald, Martin L., et al.
Publicado: (2012) -
Prion replication environment defines the fate of prion strain adaptation
por: Katorcha, Elizaveta, et al.
Publicado: (2018) -
Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis
por: Kawagishi, Naoki, et al.
Publicado: (2018)